2022-Ra-653-Esgo The Impact of Histology, Prior Therapy, and Dmmr Status on Lenvatinib + Pembrolizumab Outcomes in Patients with Advanced Endometrial Cancer: A Subgroup Analysis of Study 309/Keynote-775

AuthID
P-00Y-VYM
20
Author(s)
Lorusso, D
·
Makker, V
·
Herraez, AC
·
Monk, BJ
·
Mackay, H
·
Santin, AD
·
Moore, R
·
Baron-Hay, S
·
Ray-Coquard, I
·
Shapira-Frommer, R
·
Ushijima, K
·
Yonemori, K
·
Kim, YM
·
Guerra Alia, EM
·
Sanli, UA
·
Huang, J
·
McKenzie, J
·
Barresi, G
·
Colombo, N
Tipo de Documento
Proceedings Paper
Year published
2022
Publicado
in Endometrial cancer
Indexing
Publication Identifiers
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.